Inhaler
Latest AstraZeneca AB Patents:
- Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer
- Combination treatment by administering a recombinant apyrase protein in conjunction with a P2Yinhibitor
- Dry powder formulation for pulmonary delivery and methods of use
- POLQ inhibitors
- ORAL FORMULATION OF A THERAPEUTIC COMPOUND
Description
FIG. 1 is a perspective view of an inhaler in closed condition showing our design:
FIG. 2 is a perspective view thereof, with the inhaler in open condition and suction tube in stored position;
FIG. 3 is a perspective view thereof, with the inhaler in open condition and suction tube in usable position;
FIG. 4 is an end elevation view thereof, with the inhaler in open condition and suction tube in usable position; and,
FIG. 5 is a side elevation view thereof, with the inhaler in open condition and suction tube in usable position.
Claims
The ornamental design for an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D493519
Type: Grant
Filed: Dec 18, 2002
Date of Patent: Jul 27, 2004
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Jan Jönsson (Lund), Patrik Månsson (Malmö), Malin Orebäck (Bromma)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Fish & Richardson P.C.
Application Number: 29/172,890
Type: Grant
Filed: Dec 18, 2002
Date of Patent: Jul 27, 2004
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Jan Jönsson (Lund), Patrik Månsson (Malmö), Malin Orebäck (Bromma)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Fish & Richardson P.C.
Application Number: 29/172,890
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)
International Classification: 2902;
International Classification: 2902;